Deferoxamine and haemoglobin decreased Patient Reports February 12, 2012

Deferoxamine Side Effects Report #5690154-1
Deferoxamine side effect was reported by a Health Professional from TURKEY on Mar 19, 2008. Male patient, child 7 years of age, was treated with Deferoxamine. After drug was administered, patient experienced the following side effects: arthritis , atelectasis, blood urine present, c-reactive protein increased, erythema, haemoglobin decreased, henoch-schonlein purpura, hypertension, intussusception. Deferoxamine dosage: unknown. During the same period patient was treated with DEFEROXAMINE MESYLATE, PREDNISOLONE, CYCLOPHOSPHAMIDE, RED BLOOD CELLS, DEFERIPRONE. Patient was hospitalized. Patient recovered.

Deferoxamine Side Effects Report #5949383-1
Deferoxamine side effect was reported by a Physician from UNITED KINGDOM on Oct 28, 2008. Male patient was diagnosed with hyperparathyroidism, vitamin supplementation, hypertension and was treated with Deferoxamine. After drug was administered, patient experienced the following side effects: anti-erythropoietin antibody positive, aplasia pure red cell, aspiration bone marrow, biopsy bone marrow, blood glucose increased, fibula fracture, haemoglobin decreased, iron overload, therapeutic response decreased. Deferoxamine dosage: 350 MG, QW. During the same period patient was treated with DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE, EPREX, ALFACALCIDOL, AMLODIPINE. Patient recovered.

Deferoxamine Side Effects Report #5958513-7
Deferoxamine side effect was reported by a Health Professional from UNITED KINGDOM on Nov 10, 2008. Male patient was diagnosed with hyperparathyroidism, vitamin supplementation, hypertension and was treated with Deferoxamine. After drug was administered, patient experienced the following side effects: anti-erythropoietin antibody positive, aplasia pure red cell, aspiration bone marrow, biopsy bone marrow, blood glucose increased, fibula fracture, haemoglobin decreased, iron overload, renal transplant. Deferoxamine dosage: 350 MG, QW. During the same period patient was treated with DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE, EPREX, ALFACALCIDOL, AMLODIPINE. Patient recovered.